MindWalk Holdings Corp. (HYFT)
HYFT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-04-30, https://www.sec.gov/Archives/edgar/data/1715925/000095017025099392/0000950170-25-099392-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2025-04-30. Converted from CAD at 1.4219 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | HYFT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001715925 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $17.2M |
| Net income | -$21.3M |
| Operating income | Not in SEC XBRL data |
| Net margin | -123.3% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 4.0× |
Reported in CAD; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | F-3 | 2026-07-13 |
| Latest annual report | 20-F | 2026-07-23 |
| Latest quarterly / interim | 6-K | 2026-10-14 |
Source: SEC EDGAR submissions feed, 282 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ZYBT | Zhengye Biotechnology Holding Limited | $1.48 | -12.43% | $70.1M |
| NMAD | Nomad Power Solutions Inc. | $4.28 | +2.64% | $68.9M |
| CING | Cingulate Inc. | $4.72 | -2.48% | $68.6M |
| MAIA | MAIA Biotechnology Inc. | $1.16 | -1.70% | $71.6M |
| OSTX | OS Therapies Incorporated | $1.45 | -7.05% | $67.4M |
| SPRO | Spero Therapeutics Inc. | $1.15 | -2.54% | $67.0M |
| CTOR | Citius Oncology Inc. | $0.7920 | -2.54% | $73.6M |
| XBIT | XBiotech Inc. | $2.16 | -5.68% | $65.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier